MASLDおよびその他の慢性肝疾患におけるスタチンの有効性と安全性

関連する実験動画

Updated: Feb 22, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

I Commins^1,2, D Clayton-Chubb^1,2,3, N Janko^2,3

¹Department of Gastroenterology, Alfred Health, Melbourne, VIC 3004, Australia.

Medical sciences (Basel, Switzerland)

|February 20, 2026

まとめ

代謝機能不全に関連したステアトス性肝疾患 (MASLD) は,世界中の成人の38%に影響します. このレビューでは,心血管の健康のために一般的に使用されるスタチンを,MASLDとその合併症の潜在的な治療法として調査します.

科学分野:

肝臓病理学肝臓病理学
心臓病学心臓病学
薬理学薬理学とは

背景:

代謝機能障害に関連したステアトス性肝疾患 (MASLD) は,世界的な肝臓疾患の1つである.
MASLDは,心血管疾患,肝硬変,肝がんのリスクを高めます.
現在のMASLD治療は,ライフスタイルの変化に依存しており,新しい薬剤療法が必要になります.

研究の目的:

MASLD患者における脂質低下のためのスタチン療法に関する証拠をレビューする.
MASLDとその合併症の治療におけるスタチンの潜在的な利点を探求する.
肝疾患の文脈におけるスタチンの安全性と有効性を評価する.

主な方法:

総合的な文献レビュー.
既存の臨床試験データの分析.
肝疾患におけるスタチンの薬理学的メカニズムの評価.

主要な成果:

スタチンは,心血管疾患のリスクを減らすために広く処方されています.
MASLD治療のためにスタチンを活用する関心が高まっている.
MASLD患者におけるスタチンの有効性と安全性に関する証拠は調査中です.

結論:

スタチンは,心血管疾患のリスクを管理する上で重要な役割を果たします.
MASLDにおけるスタチンの治療的役割を確認するためにさらなる研究が必要である.
スタチンは,MASLD患者における心血管の健康と肝臓疾患の管理に双重の利益をもたらす可能性があります.

キーワード:

マスルド (MASLD) とはディスリピデミア症候群高齢者高齢者は高齢者は高齢者は高齢者は高齢者は高齢者は高齢者は高齢者は高齢者は高齢者は肝臓肝臓肝臓肝臓肝臓肝臓肝臓肝臓非アルコール性脂肪肝症とは,非アルコール性脂肪肝症です.スタチンはスタチンです.ステアトーシスステアトーシス

さらに関連する動画

Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss

Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss

Published on: July 19, 2024

Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease with Fibrosis

Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease with Fibrosis

Published on: July 18, 2025

関連する概念動画

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...

Atherosclerosis III: Management

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...

Cholesterol: Significance and Regulation

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...

Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug

Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug

In pharmacotherapy, monitoring drug concentrations is paramount, especially for drugs whose therapeutic effects hinge on both the active compound and its metabolite. Hepatic impairment profoundly influences drug potency by altering liver function. If the drug is more potent than its metabolite, impaired liver function amplifies drug activity due to elevated drug concentration levels. Conversely, if the metabolite holds greater potency, diminished liver function diminishes drug activity by...